Knut Jørgen Labori (@knutjla) 's Twitter Profile
Knut Jørgen Labori

@knutjla

Professor of Surgery & HPB surgeon, University of Oslo & Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Norway. Views are my own.

ID: 914054053109387265

calendar_today30-09-2017 09:07:23

148 Tweet

773 Followers

417 Following

Giovanni Marchegiani (@gio_marchegiani) 's Twitter Profile Photo

🫧 Cysts that are both small and stable convey a minimal risk of pancreas cancer! 🍇 2.3k patients from the Pacyfic trial 🤏 Size < 15 mm and growth < 2.5 mm/ year no higher risk of PDAC than general population onlinelibrary.wiley.com/doi/10.1002/ue… in my_UEG UEGJ

🫧 Cysts that are both small and stable convey a minimal risk of pancreas cancer!

🍇 2.3k patients from the Pacyfic trial 

🤏 Size &lt; 15 mm and growth &lt; 2.5 mm/ year no higher risk of PDAC than general population 

onlinelibrary.wiley.com/doi/10.1002/ue… in <a href="/my_ueg/">my_UEG</a> <a href="/UEGJournal/">UEGJ</a>
Marc Besselink (@marcbesselink) 's Twitter Profile Photo

Distribution of the NCCN stages of #PancreaticCancer ? 16,412 pts (2017-2022) 🇳🇱 👉23% primary resectable 👉 8% borderline resectable 👉 11% locally advanced 👉 58% metastatic ⏩️ academic.oup.com/bjs/article/11…

Distribution of the NCCN stages of #PancreaticCancer ?

16,412 pts (2017-2022) 🇳🇱 
👉23% primary resectable
👉 8% borderline resectable
👉 11% locally advanced
👉 58% metastatic 

⏩️ academic.oup.com/bjs/article/11…
Ville Sallinen (@villesallinen) 's Twitter Profile Photo

Another 💎 from DISPAIR consortium SURGERY Journal: Does neoadjuvant therapy reduce complications after left pancreatectomy? 9 high-volume centers, propensity score matched Pancreatic fistula: neoadjuvant 20% vs 24%, p=0.7 No diff in other complications. sciencedirect.com/science/articl…

Another 💎 from DISPAIR consortium <a href="/SurgJournal/">SURGERY Journal</a>: Does neoadjuvant therapy reduce complications after left pancreatectomy?

9 high-volume centers, propensity score matched

Pancreatic fistula: neoadjuvant 20% vs 24%, p=0.7

No diff in other complications.

sciencedirect.com/science/articl…
BJS (@bjsurgery) 's Twitter Profile Photo

Advancing hepatic augmentation for safer hepatic surgery: insights into portal and hepatic vein embolization strategies ➡️ doi.org/10.1093/bjs/zn… The shift from traditional PVL to combined embolization techniques marks major progress in liver surgery 📈 It's not just about

Advancing hepatic augmentation for safer hepatic surgery: insights into portal and hepatic vein embolization strategies
➡️ doi.org/10.1093/bjs/zn…

The shift from traditional PVL to combined embolization techniques marks major progress in liver surgery
📈 It's not just about
Julie Hallet (@halletjulie) 's Twitter Profile Photo

Defining high-risk pancreas #NETs🦓 496 resections 🇮🇹🇫🇷🇨🇦 Early recurrence 71% if venous thrombosis 41% if Ki 67>5% + tumor >3cm + ⬆️LN ⚠️Signs of biologically borderline-resectable NETs 🛑before resection ➡️ start with systemic💊 🔗journals.lww.com/annalsofsurger… Stefano Partelli

Defining high-risk pancreas #NETs🦓 

496 resections 🇮🇹🇫🇷🇨🇦

Early recurrence
71% if venous thrombosis
41% if Ki 67&gt;5% + tumor &gt;3cm + ⬆️LN

⚠️Signs of biologically borderline-resectable NETs

🛑before resection ➡️ start with systemic💊

🔗journals.lww.com/annalsofsurger…
<a href="/spartelli/">Stefano Partelli</a>
Knut Jørgen Labori (@knutjla) 's Twitter Profile Photo

👏Congratulations to Ingvild Farnes Ingvild Farnes for successfully defending her thesis: "Optimizing the diagnostic work-up and treatment for borderline resectable and locally advanced pancreatic cancer: Insights from the NORPACT-2 Trial". Big thanks to Prof. Ajith Siriwardena &

👏Congratulations to Ingvild Farnes <a href="/ingfifa1/">Ingvild Farnes</a> for successfully defending  her thesis: "Optimizing the diagnostic work-up and treatment for borderline resectable and locally advanced pancreatic cancer: Insights from the NORPACT-2 Trial". Big thanks to Prof. Ajith Siriwardena &amp;
Giovanni Marchegiani (@gio_marchegiani) 's Twitter Profile Photo

What is your anticoagulation practice 💉 after portal vein resection in pancreas surgery ?! 🧑‍🧑‍🧒‍🧒 1k pts / 90 days thrombosis 7% 🔮 Predictors resection type / graft material 🩸 Therapeutic anticoagulation 📉 early thrombosis but 👎 at 90 days journals.lww.com/annalsofsurger…

What is your anticoagulation practice 💉 after portal vein resection in pancreas surgery ?! 

🧑‍🧑‍🧒‍🧒 1k pts / 90 days thrombosis 7%

🔮 Predictors resection type / graft material

🩸 Therapeutic anticoagulation 📉 early thrombosis but 👎 at 90 days

journals.lww.com/annalsofsurger…
Bas Groot Koerkamp (@basgrootkoerkam) 's Twitter Profile Photo

Primary percutaneous stenting for malignant hilar biliary obstruction. No longer cholangitis or pancreatitis keeping you from systemic treatment. #cholangiocarcinoma #drainage authors.elsevier.com/sd/article/S25…

Primary percutaneous stenting for malignant hilar biliary obstruction. No longer cholangitis or pancreatitis keeping you from systemic treatment. #cholangiocarcinoma #drainage 

authors.elsevier.com/sd/article/S25…
Marc Besselink (@marcbesselink) 's Twitter Profile Photo

Endoscopic or surgical #gastroenterostomy for palliation malignant gastric outlet obstruction? 🚀Today The Lancet Gastroenterology & Hepatology: #ENDURO randomised multicenter trial DPCG 🇳🇱 Excellent nationwide collaboration #surgery & #gastroenterology 🙌 ⏩️ sciencedirect.com/science/articl…

Endoscopic or surgical #gastroenterostomy for palliation malignant gastric outlet obstruction? 

🚀Today <a href="/LancetGastroHep/">The Lancet Gastroenterology & Hepatology</a>:  #ENDURO randomised multicenter trial <a href="/DPCG_official/">DPCG</a> 🇳🇱

Excellent nationwide collaboration #surgery &amp; #gastroenterology 🙌

⏩️ sciencedirect.com/science/articl…
JAMA Surgery (@jamasurgery) 's Twitter Profile Photo

This Review highlights that difficult cholecystectomies are associated with distinct patient, disease, and imaging factors, and emphasizes the need for careful assessment, advanced imaging, and adaptable surgical strategies to prevent serious injuries. ja.ma/4nSVnGR

This Review highlights that difficult cholecystectomies are associated with distinct patient, disease, and imaging factors, and emphasizes the need for careful assessment, advanced imaging, and adaptable surgical strategies to prevent serious injuries.

ja.ma/4nSVnGR